Skip to main content
Pharmaron Beijing Co., Ltd logo

Pharmaron Beijing Co., Ltd — Investor Relations & Filings

Ticker · 3759 ISIN · CNE100003PG4 HKEX Professional, scientific and technical activities
Open in API
Filings indexed 991 across all filing types
Latest filing 2026-05-27 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 3759

About Pharmaron Beijing Co., Ltd

http://www.pharmaron.com

Pharmaron is a premier life science service provider and a comprehensive Contract Research and Manufacturing Organization (CRO/CDMO). The company delivers integrated research, development, and manufacturing capabilities across the entire drug development continuum, encompassing discovery, preclinical testing, clinical trials, and commercialization. Pharmaron's service portfolio supports diverse modalities, including small molecules, biologics, and advanced therapeutics such as cell and gene therapy (CGT) products. It partners with pharmaceutical, biotechnology, and medical device companies globally to advance their R&D pipelines.

Recent filings

Filing Released Lang Actions
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 90% confidence The document is very short (~242 characters) and merely states that an announcement has been published on the issuer’s website. It contains no substantive financial data or report content, only a notice that a document is available elsewhere. According to the “menu vs meal” rule, this is a Report Publication Announcement.
2026-05-27 English
VOLUNTARY ANNOUNCEMENT INVESTMENT IN THE CONSTRUCTION OF AN ANNUAL PRODUCTION CAPACITY IN ZHEJIANG SHAOXING
Regulatory Filings Classification · 85% confidence The document is a voluntary corporate announcement by a Hong Kong‐listed company disclosing an investment project to construct a new production capacity facility. It does not provide financial statements, earnings data, share issuance details, nor is it a meeting material or voting result. It is a general regulatory announcement under the Hong Kong Listing Rules without any financing or capital structure change. Therefore, the most appropriate category is the fallback for miscellaneous regulatory announcements: RNS.
2026-05-27 English
VOLUNTARY ANNOUNCEMENT ENTRY INTO AN INVESTMENT AGREEMENT WITH HANGZHOU QIANTANG INVESTMENT SERVICE CENTER
Regulatory Filings Classification · 84% confidence The document is a voluntary announcement under the Hong Kong Listing Rules describing the Company’s entry into an investment agreement for a new CDMO facility. There is no issuance of shares, dividend declaration, earnings data, management change, merger, or financing raise detailed. It is a general regulatory announcement that does not fit into other specific categories, so it falls into the fallback category for regulatory filings (RNS).
2026-05-27 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Report Publication Announcement Classification · 90% confidence The text is extremely short and merely states that an announcement has been published on the issuer’s website, without providing any substantive financial data or report content. It serves solely to notify the reader that a document is available elsewhere. This matches the definition of a Report Publication Announcement (RPA).
2026-05-22 English
(UPDATED) FINAL DIVIDEND IN CASH FOR THE YEAR ENDED DECEMBER 31, 2025
Notice of Dividend Amount Classification · 92% confidence The document is a Hong Kong Stock Exchange styled announcement detailing the final cash dividend for the year ended December 31, 2025. It provides ex-dividend date, record date, payment date, withholding tax details, and other dividend-specific information. This matches the criteria for a Notice of Dividend Amount (DIV), not a full financial report or proxy statement.
2026-05-21 English
Notification Letter and Request Form to Non-registered Shareholders - Notification of publication of Circular and Notices for the 2025 Annual General Meeting
Report Publication Announcement Classification · 90% confidence The document is a notification letter informing shareholders that the Circular of the 2025 Annual General Meeting and the Notice of the 2025 AGM have been published on the company’s and HKEX websites, and explains how to request printed copies. It does not contain the AGM materials themselves, but merely announces their publication and access. This matches the definition of a Report Publication Announcement (RPA).
2026-05-21 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.